Clinical trial
Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone…
NCT00326820 · Wales Cancer Trials Unit, Other · Unknown status
Key facts
| NCT number | NCT00326820 |
|---|---|
| Title | Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer |
| Official title | Zoledronate Versus Ibandronate Comparative Evaluation: A Randomized Phase III, Open-Label, Multicenter, Parallel Group Clinical Trial to Evaluate and Compare the Efficacy, Safety Profile and Tolerability of Oral Ibandronate Versus Intravenous Zoledronate in the Treatment of Breast Cancer Patients… |
| Lead sponsor | Wales Cancer Trials Unit, Other |
| Collaborators | Velindre NHS Trust |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer, Hypercalcemia of Malignancy, Metastatic Cancer |
| Intervention type | Drug |
| Interventions | ibandronate sodium, zoledronic acid, Zolendronic Acid |
| Enrollment | 1,404 |
| Start date | Jan 1, 2006 |
| Primary completion | Dec 1, 2012 |
| Completion | Oct 1, 2015 |
| First posted | May 17, 2006 |
| Last update posted | Mar 13, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: